The KM curves indicated that risk scores showed excellent ability to predict prognoses in BC patients stratified by T/N stage, pathologic stage, age, ER status, PR status, HER2 status, and non-TNBC/TNBC status (Figures 12A–T). This evidence concerns the gene ERBB2 and breast cancer.